rediff News http://www.rediff.com/tags/basel+iii India's largest news and entertainment service online.. en-us Fri, 09 Dec 16 17:48:54 +0000 Fri, 09 Dec 16 17:48:54 +0000 http://www.rediff.com/push Rediff feeds Copyright: (C) 2009 Rediff.com India Limited. All Rights Reserved. <![CDATA[Govt infusion in banks still short, say Icra & Fitch]]> http://www.rediff.com/money/report/govt-infusion-in-banks-still-short-say-icra-fitch/20160721.htm Fri, 09 Dec 2016 23:18:54 +0530 <![CDATA[Indian banks need $90 billion to meet Basel III rules: Fitch]]> http://www.rediff.com/money/report/indian-banks-need-90-billion-to-meet-basel-iii-rules-fitch/20160705.htm Fri, 09 Dec 2016 23:18:54 +0530 <![CDATA[Govt may infuse Rs 19k cr into PSU banks in FY16]]> http://www.rediff.com/money/report/govt-may-infuse-rs-19k-cr-into-psu-banks-in-fy16/20150624.htm Fri, 09 Dec 2016 23:18:54 +0530 <![CDATA[Basel III deferral to ease pressure on banks: India Ratings]]> http://www.rediff.com/money/report/basel-iii-deferral-to-ease-pressure-on-banks-india-ratings/20140328.htm Fri, 09 Dec 2016 23:18:54 +0530 <![CDATA[Banks may face hurdles to raise funds under Basel III]]> http://www.rediff.com/money/report/banks-may-face-hurdles-to-raise-funds-under-basel-iii/20130122.htm Fri, 09 Dec 2016 23:18:54 +0530 <![CDATA[Valley National Bancorp Announces Commencement Of Common Stock Offering]]> http://in.advfn.com/news_Valley-National-Bancorp-Announces-Commencement-Of_73098309.html Fri, 09 Dec 2016 23:18:54 +0530 <![CDATA[State Bank of Travancore approves raising of Rs. 600 crores]]> http://www.equitybulls.com/admin/news2006/news_det.asp?id=197271 Fri, 09 Dec 2016 23:18:54 +0530 <![CDATA[CARE reviews Credit Rating of Andhra Bank]]> http://www.equitybulls.com/admin/news2006/news_det.asp?id=197301 Fri, 09 Dec 2016 23:18:54 +0530 <![CDATA[SBT to raise up to Rs 600 cr via Basel-III bonds]]> http://smartinvestor.business-standard.com/market/Compnews-428760-Compnewsdet-SBT_to_raise_up_to_Rs_600_cr_via_Basel_III_bonds.htm Fri, 09 Dec 2016 23:18:54 +0530 <![CDATA[Novartis announces Zykadia® first-line study results showing 16.6 month progression-free survival in patients with ALK+ advanced NSCLC]]> https://www.asianhhm.com/prnews/novartis-announces-zykadia-first-line-study-results-showing-16-6-month-progression-free-survival-in-patients-with-alk-advanced-nsclc Fri, 09 Dec 2016 23:18:54 +0530